Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

August 01, 2013; Volume 41,Issue 8
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Andersson, Tommy B.

    1. You have access
      Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

B

  1. Bäckström, Tobias

    1. You have access
      Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316
  2. Barrett, Kathleen G.

    1. You have access
      Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912
  3. Beijnen, Jos H.

    1. You have access
      Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971
  4. Bertilsson, Leif

    1. You have access
      Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316
  5. Björkhem-Bergman, Linda

    1. You have access
      Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316
  6. Bredberg, Eva

    1. You have access
      Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

C

  1. Chang, Shu-Ying

    1. You have access
      Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940
  2. Chaudhry, Amarjit S.

    1. You have access
      Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672
  3. Choi, Yeon Jae

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  4. Clouser-Roche, Andrea

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

D

  1. Daali, Youssef

    1. You have access
      Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
      Youssef Daali, Philippe Millet, Pierre Dayer and Catherine M. Pastor
      Drug Metabolism and Disposition August 2013, 41 (8) 1548-1556; DOI: https://doi.org/10.1124/dmd.113.051870
  2. Dayer, Pierre

    1. You have access
      Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
      Youssef Daali, Philippe Millet, Pierre Dayer and Catherine M. Pastor
      Drug Metabolism and Disposition August 2013, 41 (8) 1548-1556; DOI: https://doi.org/10.1124/dmd.113.051870
  3. de Graaf, Inge A.M.

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585
  4. de Jager, Marina H.

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585
  5. de Waard, Hans

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585
  6. Diczfalusy, Ulf

    1. You have access
      Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316
  7. Dinter-Heidorn, Heike

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585
  8. Doi, Mami

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

E

  1. Edmonds, David J.

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  2. Eng, Heather

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

F

  1. Fan, Yiping

    1. You have access
      Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672
  2. Fang, Hailin

    1. You have access
      Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912
  3. Fenner, Katherine

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193
  4. Ferenci, Peter

    1. You have access
      Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
      Katrin Wlcek, Fabienne Koller, Peter Ferenci and Bruno Stieger
      Drug Metabolism and Disposition August 2013, 41 (8) 1522-1528; DOI: https://doi.org/10.1124/dmd.113.051037
  5. Fortin, Jean-Philippe

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  6. Freiwald, Sascha

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193
  7. Frijlink, Henderik W.

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585
  8. Fujiyama, Atsushi

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  9. Fukudo, Masahide

    1. You have access
      Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats
      Sachiko Kunimatsu, Tomoyuki Mizuno, Masahide Fukudo and Toshiya Katsura
      Drug Metabolism and Disposition August 2013, 41 (8) 1592-1597; DOI: https://doi.org/10.1124/dmd.112.050286

G

  1. Gargano, Mary D.

    1. You have access
      Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912
  2. Ghim, Jong Lyul

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  3. Griffith, David A.

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  4. Groothuis, Geny M.M.

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585
  5. Grubb, Mary F.

    1. You have access
      Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

H

  1. Handa, Makoto

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  2. Hashimoto, Takashi

    1. You have access
      In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680
  3. Hayeshi, Rose

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585
  4. Hinrichs, Wouter L.J.

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

I

  1. Ikeda, Yasuo

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  2. Isoherranen, Nina

    1. You have access
      Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

J

  1. Jackson, Margaret

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  2. Jeong, Eun Sook

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862

K

  1. Kalgutkar, Amit S.

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  2. Katsura, Toshiya

    1. You have access
      Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats
      Sachiko Kunimatsu, Tomoyuki Mizuno, Masahide Fukudo and Toshiya Katsura
      Drug Metabolism and Disposition August 2013, 41 (8) 1592-1597; DOI: https://doi.org/10.1124/dmd.112.050286
  3. Kim, Dong-Hyun

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  4. Kim, Hyo-Ji

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  5. Klaassen, Curtis D.

    1. You have access
      Tissue Distribution, Ontogeny, and Chemical Induction of Aldo-Keto Reductases in Mice
      Matthew Pratt-Hyatt, Andrew J. Lickteig and Curtis D. Klaassen
      Drug Metabolism and Disposition August 2013, 41 (8) 1480-1487; DOI: https://doi.org/10.1124/dmd.113.051904
  6. Kocarek, Thomas A.

    1. You have access
      Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912
  7. Koller, Fabienne

    1. You have access
      Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
      Katrin Wlcek, Fabienne Koller, Peter Ferenci and Bruno Stieger
      Drug Metabolism and Disposition August 2013, 41 (8) 1522-1528; DOI: https://doi.org/10.1124/dmd.113.051037
  8. Konno, Yoshihiro

    1. You have access
      In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680
  9. Kunimatsu, Sachiko

    1. You have access
      Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats
      Sachiko Kunimatsu, Tomoyuki Mizuno, Masahide Fukudo and Toshiya Katsura
      Drug Metabolism and Disposition August 2013, 41 (8) 1592-1597; DOI: https://doi.org/10.1124/dmd.112.050286

L

  1. Lee, Caroline A.

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193
  2. Lee, Su-Jun

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  3. Li, Xianping

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  4. Lickteig, Andrew J.

    1. You have access
      Tissue Distribution, Ontogeny, and Chemical Induction of Aldo-Keto Reductases in Mice
      Matthew Pratt-Hyatt, Andrew J. Lickteig and Curtis D. Klaassen
      Drug Metabolism and Disposition August 2013, 41 (8) 1480-1487; DOI: https://doi.org/10.1124/dmd.113.051904
  5. Limberakis, Chris

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183

M

  1. Maas-Bakker, Roel F.

    1. You have access
      Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971
  2. Markovich, Daniel

    1. You have access
      Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912
  3. Maruyama, Toru

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  4. Matsuda, Yoshiki

    1. You have access
      In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680
  5. McDonald, Thomas S.

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  6. Meijerman, Irma

    1. You have access
      Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971
  7. Millet, Philippe

    1. You have access
      Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
      Youssef Daali, Philippe Millet, Pierre Dayer and Catherine M. Pastor
      Drug Metabolism and Disposition August 2013, 41 (8) 1548-1556; DOI: https://doi.org/10.1124/dmd.113.051870
  8. Mizuno, Tomoyuki

    1. You have access
      Effect of P-Glycoprotein and Breast Cancer Resistance Protein Inhibition on the Pharmacokinetics of Sunitinib in Rats
      Sachiko Kunimatsu, Tomoyuki Mizuno, Masahide Fukudo and Toshiya Katsura
      Drug Metabolism and Disposition August 2013, 41 (8) 1592-1597; DOI: https://doi.org/10.1124/dmd.112.050286
  9. Mooiman, Kim D.

    1. You have access
      Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971
  10. Moret, Ed E.

    1. You have access
      Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971

N

  1. Nagai, Mika

    1. You have access
      In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680
  2. Nolte, Whitney M.

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  3. Nylén, Hanna

    1. You have access
      Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316

O

  1. Ogaki, Shigeru

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  2. Okamura, Yosuke

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  3. Otagiri, Masaki

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005

P

  1. Pastor, Catherine M.

    1. You have access
      Evidence of Drug-Drug Interactions through Uptake and Efflux Transport Systems in Rat Hepatocytes: Implications for Cellular Concentrations of Competing Drugs
      Youssef Daali, Philippe Millet, Pierre Dayer and Catherine M. Pastor
      Drug Metabolism and Disposition August 2013, 41 (8) 1548-1556; DOI: https://doi.org/10.1124/dmd.113.051870
  2. Peng, Chi-Chi

    1. You have access
      Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940
  3. Pratt-Hyatt, Matthew

    1. You have access
      Tissue Distribution, Ontogeny, and Chemical Induction of Aldo-Keto Reductases in Mice
      Matthew Pratt-Hyatt, Andrew J. Lickteig and Curtis D. Klaassen
      Drug Metabolism and Disposition August 2013, 41 (8) 1480-1487; DOI: https://doi.org/10.1124/dmd.113.051904
  4. Price, David A.

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  5. Proost, Johannes H.

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

R

  1. Reyner, Eric L.

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193
  2. Rodrigues, A. David

    1. You have access
      Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940
  3. Rönquist-Nii, Yuko

    1. You have access
      Comparison of Endogenous 4β-Hydroxycholesterol with Midazolam as Markers for CYP3A4 Induction by Rifampicin
      Linda Björkhem-Bergman, Tobias Bäckström, Hanna Nylén, Yuko Rönquist-Nii, Eva Bredberg, Tommy B. Andersson, Leif Bertilsson and Ulf Diczfalusy
      Drug Metabolism and Disposition August 2013, 41 (8) 1488-1493; DOI: https://doi.org/10.1124/dmd.113.052316
  4. Runge-Morris, Melissa

    1. You have access
      Regulation of Murine Hepatic Hydroxysteroid Sulfotransferase Expression in Hyposulfatemic Mice and in a Cell Model of 3′-Phosphoadenosine-5′-Phosphosulfate Deficiency
      Kathleen G. Barrett, Hailin Fang, Mary D. Gargano, Daniel Markovich, Thomas A. Kocarek and Melissa Runge-Morris
      Drug Metabolism and Disposition August 2013, 41 (8) 1505-1513; DOI: https://doi.org/10.1124/dmd.113.051912

S

  1. Satsukawa, Masahiro

    1. You have access
      In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680
  2. Schellens, Jan H. M.

    1. You have access
      Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction
      Kim D. Mooiman, Roel F. Maas-Bakker, Ed E. Moret, Jos H. Beijnen, Jan H. M. Schellens and Irma Meijerman
      Drug Metabolism and Disposition August 2013, 41 (8) 1494-1504; DOI: https://doi.org/10.1124/dmd.113.050971
  3. Schuetz, Erin G.

    1. You have access
      Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672
  4. Seo, Kyung-Ah

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  5. Sevidal, Samantha

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193
  6. Sharma, Raman

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  7. Shin, Jae-Gook

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  8. Shin, Kye Jung

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  9. Shirasaka, Yoshiyuki

    1. You have access
      Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940
  10. Siissalo, Sanna

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585
  11. Smith, Bill J.

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193
  12. Sohn, Dong-Ryul

    1. You have access
      Glucuronidation of a Sarpogrelate Active Metabolite Is Mediated by UDP-Glucuronosyltransferases 1A4, 1A9, and 2B4
      Hyo-Ji Kim, Eun Sook Jeong, Kyung-Ah Seo, Kye Jung Shin, Yeon Jae Choi, Su-Jun Lee, Jong Lyul Ghim, Dong-Ryul Sohn, Jae-Gook Shin and Dong-Hyun Kim
      Drug Metabolism and Disposition August 2013, 41 (8) 1529-1537; DOI: https://doi.org/10.1124/dmd.113.051862
  13. Stevens, Benjamin D.

    1. You have access
      Demonstration of the Innate Electrophilicity of 4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a Small-Molecule Positive Allosteric Modulator of the Glucagon-Like Peptide-1 Receptor
      Heather Eng, Raman Sharma, Thomas S. McDonald, David J. Edmonds, Jean-Philippe Fortin, Xianping Li, Benjamin D. Stevens, David A. Griffith, Chris Limberakis, Whitney M. Nolte, David A. Price, Margaret Jackson and Amit S. Kalgutkar
      Drug Metabolism and Disposition August 2013, 41 (8) 1470-1479; DOI: https://doi.org/10.1124/dmd.113.052183
  14. Stieger, Bruno

    1. You have access
      Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
      Katrin Wlcek, Fabienne Koller, Peter Ferenci and Bruno Stieger
      Drug Metabolism and Disposition August 2013, 41 (8) 1522-1528; DOI: https://doi.org/10.1124/dmd.113.051037
  15. Strom, Stephen C.

    1. You have access
      Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672

T

  1. Taguchi, Kazuaki

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  2. Taguchi, Takayuki

    1. You have access
      In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680
  3. Takeoka, Shinji

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  4. Thirumaran, Ranjit K.

    1. You have access
      Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672
  5. Thummel, Kenneth E.

    1. You have access
      Effect of CYP3A5 Expression on the Inhibition of CYP3A-Catalyzed Drug Metabolism: Impact on Modeling CYP3A-Mediated Drug-Drug Interactions
      Yoshiyuki Shirasaka, Shu-Ying Chang, Mary F. Grubb, Chi-Chi Peng, Kenneth E. Thummel, Nina Isoherranen and A. David Rodrigues
      Drug Metabolism and Disposition August 2013, 41 (8) 1566-1574; DOI: https://doi.org/10.1124/dmd.112.049940

U

  1. Ujihira, Hayato

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  2. Ullah, Mohammed

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193

V

  1. van Dam, Annie

    1. You have access
      Nanoparticle Formulation of a Poorly Soluble Cannabinoid Receptor 1 Antagonist Improves Absorption by Rat and Human Intestine
      Sanna Siissalo, Hans de Waard, Marina H. de Jager, Rose Hayeshi, Henderik W. Frijlink, Wouter L.J. Hinrichs, Heike Dinter-Heidorn, Annie van Dam, Johannes H. Proost, Geny M.M. Groothuis and Inge A.M. de Graaf
      Drug Metabolism and Disposition August 2013, 41 (8) 1557-1565; DOI: https://doi.org/10.1124/dmd.112.049585

W

  1. Watanabe, Hiroshi

    1. You have access
      Pharmacokinetic Study of the Structural Components of Adenosine Diphosphate-Encapsulated Liposomes Coated with Fibrinogen γ-Chain Dodecapeptide as a Synthetic Platelet Substitute
      Kazuaki Taguchi, Hayato Ujihira, Shigeru Ogaki, Hiroshi Watanabe, Atsushi Fujiyama, Mami Doi, Yosuke Okamura, Shinji Takeoka, Yasuo Ikeda, Makoto Handa, Masaki Otagiri and Toru Maruyama
      Drug Metabolism and Disposition August 2013, 41 (8) 1584-1591; DOI: https://doi.org/10.1124/dmd.112.050005
  2. West, Mark A.

    1. You have access
      In Vitro Characterization of Axitinib Interactions with Human Efflux and Hepatic Uptake Transporters: Implications for Disposition and Drug Interactions
      Eric L. Reyner, Samantha Sevidal, Mark A. West, Andrea Clouser-Roche, Sascha Freiwald, Katherine Fenner, Mohammed Ullah, Caroline A. Lee and Bill J. Smith
      Drug Metabolism and Disposition August 2013, 41 (8) 1575-1583; DOI: https://doi.org/10.1124/dmd.113.051193
  3. Wlcek, Katrin

    1. You have access
      Hepatocellular Organic Anion–Transporting Polypeptides (OATPs) and Multidrug Resistance–Associated Protein 2 (MRP2) Are Inhibited by Silibinin
      Katrin Wlcek, Fabienne Koller, Peter Ferenci and Bruno Stieger
      Drug Metabolism and Disposition August 2013, 41 (8) 1522-1528; DOI: https://doi.org/10.1124/dmd.113.051037

Y

  1. Yamashita, Shinji

    1. You have access
      In Vivo Assessment of the Impact of Efflux Transporter on Oral Drug Absorption Using Portal Vein–Cannulated Rats
      Yoshiki Matsuda, Yoshihiro Konno, Takashi Hashimoto, Mika Nagai, Takayuki Taguchi, Masahiro Satsukawa and Shinji Yamashita
      Drug Metabolism and Disposition August 2013, 41 (8) 1514-1521; DOI: https://doi.org/10.1124/dmd.113.051680
  2. Yang, Xia

    1. You have access
      Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672
  3. Yasuda, Kazuto

    1. You have access
      Genetic Variation in Aldo-Keto Reductase 1D1 (AKR1D1) Affects the Expression and Activity of Multiple Cytochrome P450s
      Amarjit S. Chaudhry, Ranjit K. Thirumaran, Kazuto Yasuda, Xia Yang, Yiping Fan, Stephen C. Strom and Erin G. Schuetz
      Drug Metabolism and Disposition August 2013, 41 (8) 1538-1547; DOI: https://doi.org/10.1124/dmd.113.051672
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 41 (8)
Drug Metabolism and Disposition
Vol. 41, Issue 8
1 Aug 2013
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics